Dr. Armen Margaryan, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5210 Linton Blvd, Suite #105, Delray Beach, FL 33484 Phone: 561-496-1160 Fax: 561-496-2660 |
David Adam Scott, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5210 Linton Blvd, Suite 105, Delray Beach, FL 33484 Phone: 561-496-1160 Fax: 561-496-2660 |
Dr. Joseph Z Krause, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 5162 Linton Blvd, Ste 102, Delray Beach, FL 33484 Phone: 561-499-5100 Fax: 561-499-5133 |
Chintan Vimalkumar Shah, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5210 Linton Blvd, Suite 105, Delray Beach, FL 33484 Phone: 561-496-1160 |
Dr. Lon M Sadowsky, D.O. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5210 Linton Blvd, Suite 105, Delray Beach, FL 33484 Phone: 561-496-1160 Fax: 561-496-2660 |
News Archive
A Florida researcher reports that a prescription nasal spray approved for adults with migraines also helps teenagers and potentially offers relief for a population which is underserved in this respect.
A highly promising new study published on the preprint server medRxiv in April 2020 reports an efficient new method to conduct high-throughput testing of blood samples for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which is causing the rapidly spreading pandemic of COVID-19 disease throughout the world. The method could revolutionize the diagnosis of new cases before they become symptomatic.
Evidence of autism may be found in the composition and malfunction of the brain's blood vessels, a team of scientists has found. Their research sheds new light on the causes of autism, which previously had pointed to neurological make-up rather than to the vascular system, and identifies a new target for potential therapeutic intervention.
New cancer drugs taken in pill form have become dramatically more expensive in their first year on the market compared with drugs launched 15 years ago, a University of North Carolina at Chapel Hill study has found. The findings call into question the sustainability of a system that sets high prices at market entry in addition to rapidly increasing those prices over time.
OrthoAccel Technologies, Inc., developers of the AcceleDent System, which is an acceleration device to enhance orthodontics, announced the availability of a new Continuing Education course published by PennWell Corporation, a leader in professional education for many industries, including medicine and dentistry.
› Verified 7 days ago